MAXIMUS (NYSE:MMS) had its price objective decreased by Canaccord Genuity from $71.00 to $65.00 in a report published on Friday. Canaccord Genuity currently has a hold rating on the health services provider’s stock.

A number of other analysts have also weighed in on MMS. Maxim Group reissued a hold rating and issued a $69.00 price target (up previously from $66.00) on shares of MAXIMUS in a report on Thursday, February 8th. Zacks Investment Research raised shares of MAXIMUS from a sell rating to a hold rating in a report on Wednesday, January 17th. One analyst has rated the stock with a sell rating and six have assigned a hold rating to the company’s stock. The stock presently has a consensus rating of Hold and a consensus target price of $67.00.

Shares of MAXIMUS (MMS) opened at $64.45 on Friday. The company has a quick ratio of 2.57, a current ratio of 2.57 and a debt-to-equity ratio of 0.01. The firm has a market cap of $4,200.00, a P/E ratio of 19.18, a P/E/G ratio of 2.09 and a beta of 1.21. MAXIMUS has a fifty-two week low of $55.18 and a fifty-two week high of $72.71.

MAXIMUS (NYSE:MMS) last issued its quarterly earnings results on Thursday, February 8th. The health services provider reported $0.78 earnings per share for the quarter, beating analysts’ consensus estimates of $0.77 by $0.01. The business had revenue of $623.10 million during the quarter, compared to analyst estimates of $624.36 million. MAXIMUS had a net margin of 8.99% and a return on equity of 22.93%. MAXIMUS’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.71 earnings per share. research analysts expect that MAXIMUS will post 3.48 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, February 28th. Shareholders of record on Thursday, February 15th will be issued a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date of this dividend is Wednesday, February 14th. MAXIMUS’s dividend payout ratio is presently 5.36%.

In other MAXIMUS news, insider Mark Andrekovich sold 2,700 shares of MAXIMUS stock in a transaction on Friday, December 15th. The shares were sold at an average price of $72.00, for a total transaction of $194,400.00. Following the completion of the sale, the insider now owns 20,296 shares of the company’s stock, valued at approximately $1,461,312. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Russell A. Beliveau sold 1,000 shares of MAXIMUS stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $71.73, for a total transaction of $71,730.00. The disclosure for this sale can be found here. Insiders have sold a total of 67,517 shares of company stock valued at $4,653,302 in the last ninety days. Company insiders own 2.48% of the company’s stock.

Several hedge funds have recently made changes to their positions in the company. Public Employees Retirement System of Ohio grew its holdings in shares of MAXIMUS by 0.3% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 73,252 shares of the health services provider’s stock valued at $4,588,000 after buying an additional 207 shares during the period. Stifel Financial Corp grew its holdings in shares of MAXIMUS by 5.2% in the 2nd quarter. Stifel Financial Corp now owns 9,186 shares of the health services provider’s stock valued at $576,000 after buying an additional 455 shares during the period. Ameritas Investment Partners Inc. grew its holdings in shares of MAXIMUS by 2.1% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 25,038 shares of the health services provider’s stock valued at $1,568,000 after buying an additional 517 shares during the period. Cubist Systematic Strategies LLC grew its holdings in shares of MAXIMUS by 16.0% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 3,969 shares of the health services provider’s stock valued at $249,000 after buying an additional 546 shares during the period. Finally, UBS Asset Management Americas Inc. grew its holdings in shares of MAXIMUS by 1.7% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 34,898 shares of the health services provider’s stock valued at $2,186,000 after buying an additional 592 shares during the period. 95.55% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This story was originally posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this story on another publication, it was copied illegally and reposted in violation of United States and international copyright and trademark legislation. The legal version of this story can be accessed at https://theolympiareport.com/2018/02/13/maximus-mms-price-target-cut-to-65-00.html.

About MAXIMUS

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.